# Clinical Outcome of Vinpocetine in Diabetic Nephropathy

> **NCT06441591** · PHASE2,PHASE3 · RECRUITING · sponsor: **Ain Shams University** · enrollment: 64 (estimated)

## Conditions studied

- Diabetic Kidney Disease
- Diabetic Nephropathies

## Interventions

- **DRUG:** Vinpocetine
- **DRUG:** Standard Therapy
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06441591
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-10
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2024-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06441591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06441591, "Clinical Outcome of Vinpocetine in Diabetic Nephropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06441591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*